Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche
15
0
0
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
6.7%
1 terminated/withdrawn out of 15 trials
87.5%
+1.0% vs industry average
7%
1 trials in Phase 3/4
0%
0 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
Impact of Bronchial Drainage Technique by the Medical Device Simeox® on Respiratory Function and Symptoms in Adult Patients With Cystic Fibrosis
Role: lead
Home Tele-Monitoring of Non-Invasive Ventilation in COPD Patients in France
Role: lead
Robot-assisted and Connected 6-minute Walk Test (TM6)
Role: lead
Efficacy of Oxygen Therapy Delivered by Systems Using Oxygen-Saving Valves in COPD Patients
Role: lead
Evaluation of the Right Use of Inhaled Therapeutics
Role: lead
Cohort of Respiratory Failure Patients Treated for the First Time With Non-Invasive Ventilation at Home
Role: lead
Evaluation of the Awakening Capability by a Vibrating Bracelet (BRASSARD)
Role: lead
Non Invasive Ventilation : Efficacy of a New Ventilatory Mode in Patients With OHS
Role: lead
Nocturnal PtcCO2 Monitoring in Patients With Amyotrophic Lateral Sclerosis (ALS)
Role: lead
Long-term Oxygen Treatment (LTOT) in Chronic Obstructive Pulmonary Disease: Factors Influencing Survival
Role: lead
Database of Patients Treated With Respiratory Support
Role: lead
Efficacy of autoPPC for the Treatment of Obstructive Sleep Apnea Syndrome (OSAS)
Role: lead
Assist Control Versus Pressure Support Modes for Domiciliary Noninvasive Ventilation in Chronic Respiratory Failure
Role: lead
Oxygen Portable Concentrator During Exercises in Patients With COPD
Role: lead
Continuous Versus Short Infusions of Ceftazidime in Cystic Fibrosis
Role: lead
All 15 trials loaded